Novartis AG
Pyridinone derivatives and their use as selective ALK-2 inhibitors

Abstract:

The invention relates to a compound of Formula I or a pharmaceutically acceptable salt thereof, a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition. ##STR00001##